Literature DB >> 35066729

Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).

Hang Su1, Weihong Ren2, Dai Zhang3.   

Abstract

Gastric cancer (GC) is one of the most common types of tumors and the most common cause of cancer mortality worldwide. The diagnosis of GC is critical to its prevention and treatment. Available tumor markers are the crucial step for GC diagnosis. Recent studies have shown that proteins in exosomes are potential diagnostic and prognostic markers for GC. Exosomes, secreted by cells, are cup-shaped with a diameter of 30-150 nm under the electron microscope. They are also surrounded by lipid bilayers and are widely found in various body fluids. Exosomes contain proteins, lipids and nucleic acid. The examination of exosomal proteins has the advantages of quickness, easy sampling, and low pain and cost, as compared with the routine inspection method of GC, which may lead to marked developments in GC diagnosis. This article summarized the exosomal proteins with a diagnostic and prognostic potential in GC, as well as exosomal proteins involved in GC progression.
© 2022. The Author(s).

Entities:  

Keywords:  Diagnosis; Exosomal protein; Gastric cancer marker

Year:  2022        PMID: 35066729     DOI: 10.1007/s10238-022-00793-5

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  145 in total

1.  A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.

Authors:  Huakang Tu; Liping Sun; Xiao Dong; Yuehua Gong; Qian Xu; Jingjing Jing; Roberd M Bostick; Xifeng Wu; Yuan Yuan
Journal:  Am J Gastroenterol       Date:  2017-03-21       Impact factor: 10.864

2.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

Review 3.  Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer.

Authors:  Liangdi Jiang; Yongwei Gu; Yue Du; Jiyong Liu
Journal:  Mol Pharm       Date:  2019-07-10       Impact factor: 4.939

4.  Diagnostic value of RNA for hepatocellular carcinoma: a network meta-analysis.

Authors:  Zhuo Han; Keming Li; Jinyu Wu; Keyan Wang; Cuipeng Qiu; Hua Ye; Chi Cui; Chunhua Song; Kaijuan Wang; Jianxiang Shi; Peng Wang; Jianying Zhang
Journal:  Biomark Med       Date:  2021-11-16       Impact factor: 2.851

Review 5.  Function of the tetraspanin molecule CD81 in B and T cells.

Authors:  Shoshana Levy
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

6.  Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.

Authors:  Wenwen Han; Xiangzhen Bu; Yanli Liu; Fang Liu; Yujie Ren; Yongsheng Cui; Shuhong Kong
Journal:  World J Surg Oncol       Date:  2021-09-18       Impact factor: 2.754

Review 7.  Exosomes: an overview of biogenesis, composition and role in ovarian cancer.

Authors:  Allison Beach; Huang-Ge Zhang; Mariusz Z Ratajczak; Sham S Kakar
Journal:  J Ovarian Res       Date:  2014-01-25       Impact factor: 4.234

8.  The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research.

Authors:  Yuling Tong; Yulian Wu; Zhenya Song; Yingying Yu; Xinyan Yu
Journal:  BMC Gastroenterol       Date:  2017-07-20       Impact factor: 3.067

9.  Exosomal TRIM3 is a novel marker and therapy target for gastric cancer.

Authors:  Hailong Fu; Huan Yang; Xu Zhang; Bo Wang; Jiahui Mao; Xia Li; Mei Wang; Bin Zhang; Zixuan Sun; Hui Qian; Wenrong Xu
Journal:  J Exp Clin Cancer Res       Date:  2018-07-21

10.  Identification of Key Circulating Exosomal microRNAs in Gastric Cancer.

Authors:  Xiaoqing Qian; Feng Xie; Huabing Wei; Daxiang Cui
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.